Anger as Trump alleged to have offered $1bn for German coronavirus vaccine
US president reportedly tried to secure exclusive control of vaccine supply

President Donald Trump has prompted anger after reportedly offering a German medical company “large sums of money” for exclusive rights to a future coronavirus vaccine.
According to Germany’s Welt am Sonntag, the US president offered $1bn (£809m) to biopharmaceutical company CureVac to secure the vaccine “only for the United States”.
However, in a press release, the company rejected “any claims on a possible sale of the company or its technology”.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Head of the company’s biggest investor, Christof Hettich, added that an exclusive contract with the US was out of the question, adding: “We want to develop a vaccine for the whole world and not individual countries.”
–––––––––––––––––––––––––––––––For a round-up of the most important stories from around the world - and a concise, refreshing and balanced take on the week’s news agenda - try The Week magazine. Get your first six issues for £6–––––––––––––––––––––––––––––––
Responding the news of Trump’s alleged offer, German economic minister, Peter Altmaier, warned the president that “Germany is not for sale”. The Guardian reports that German health minister, Jens Spahn, added that exclusive access to the vaccine for the Trump administration was “off the table”.
In the US, immigration lawyer Greg Siskind tweeted that Trump’s move to poach the vaccine from an apparently allied nation was “basically declaring war on the world”.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
The New York Times reports that two senior American officials claim German news accounts have been “overblown”, specifically referencing “any effort by the United States to secure exclusive access to a vaccine”.
However, Deutsche Welle adds that Germany’s interior minister, Horst Seehofer, said that crisis meetings with ministers today will include discussion of a German defence strategy for the firm.
CureVac was founded 20 years ago by scientists at Tübingen University, with The Times reporting that the firm is privately owned and has raised at least €360m (£324m) from investors including the Bill and Melinda Gates Foundation.
The company hopes to have an experimental vaccine developed by June or July, and then to secure approval for testing on people.
Reporting on Trump’s handling of the coronavirus pandemic so far, CNN said that the president has “performed in such an underwhelming fashion that you have to wonder whether something is wrong”.
-
Why ‘anti-Islam’ bikers are guarding Gaza aid sites
In The Spotlight Members of Infidels MC, who regard themselves as modern Crusaders, among private security guards at Gaza Humanitarian Foundation sites
-
China: Xi seeks to fill America’s void
Feature Trump’s tariffs are pushing nations eastward as Xi Jinping focuses on strengthening ties with global leaders
-
Rebrands: Bringing back the War Department
Feature Trump revives the Department of Defense’s former name
-
Supreme Court: Will it allow Trump’s tariffs?
Feature Justices fast-track Trump’s appeal to see if his sweeping tariffs are unconstitutional
-
RFK Jr.’s anti-vaccine crusade comes under fire
Feature Robert F. Kennedy Jr. faced a heated hearing as senators accused him of lying and spreading chaos
-
Venezuela: Was Trump’s air strike legal?
Feature A Trump-ordered airstrike targeted a speedboat off the coast of Venezuela, killing all 11 passengers on board
-
3 killed in Trump’s second Venezuelan boat strike
Speed Read Legal experts said Trump had no authority to order extrajudicial executions of noncombatants
-
Is Kash Patel’s fate sealed after Kirk shooting missteps?
TODAY'S BIG QUESTION The FBI’s bungled response in the immediate aftermath of the Charlie Kirk shooting has director Kash Patel in the hot seat
-
Russian drone tests Romania as Trump spins
Speed Read Trump is ‘resisting congressional plans to impose newer and tougher penalties on Russia’s energy sector’
-
Trump renews push to fire Cook before Fed meeting
Speed Read The push to remove Cook has ‘quickly become the defining battle in Trump’s effort to take control of the Fed’
-
Will Donald Trump’s second state visit be a diplomatic disaster?
Today's Big Question Charlie Kirk shooting, Saturday’s far-right rally and continued Jeffrey Epstein fallout ramps-up risks of already fraught trip